Wei‐Qin Tong

1.2k total citations
16 papers, 916 citations indexed

About

Wei‐Qin Tong is a scholar working on Pharmaceutical Science, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Wei‐Qin Tong has authored 16 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmaceutical Science, 8 papers in Molecular Biology and 5 papers in Materials Chemistry. Recurrent topics in Wei‐Qin Tong's work include Drug Solubulity and Delivery Systems (11 papers), Crystallization and Solubility Studies (5 papers) and Analytical Chemistry and Chromatography (4 papers). Wei‐Qin Tong is often cited by papers focused on Drug Solubulity and Delivery Systems (11 papers), Crystallization and Solubility Studies (5 papers) and Analytical Chemistry and Chromatography (4 papers). Wei‐Qin Tong collaborates with scholars based in United States, Switzerland and Cyprus. Wei‐Qin Tong's co-authors include Madhav Vasanthavada, Yatindra M. Joshi, M. Serpil Kislalioglu, Abu T.M. Serajuddin, John L. Lach, J. Keith Guillory, Jay Lakshman, Ting‐Fong Chin, Indrajit Ghosh and Sudha Rani Vippagunta and has published in prestigious journals such as Journal of Medicinal Chemistry, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Wei‐Qin Tong

16 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei‐Qin Tong United States	12	497	388	297	170	121	16	916
Hitesh Chokshi United States	17	616 1.2×	303 0.8×	334 1.1×	246 1.4×	90 0.7×	27	1.1k
Yuejie Chen China	12	490 1.0×	156 0.4×	297 1.0×	105 0.6×	138 1.1×	21	791
D. Franchi Italy	7	256 0.5×	144 0.4×	162 0.5×	111 0.7×	56 0.5×	12	595
Pralhad Tayade India	7	339 0.7×	132 0.3×	165 0.6×	92 0.5×	63 0.5×	7	653
Tiehua Huang United States	11	399 0.8×	120 0.3×	154 0.5×	140 0.8×	42 0.3×	11	721
Yi Jin China	16	177 0.4×	178 0.5×	128 0.4×	65 0.4×	354 2.9×	55	775
Konstantin Tsinman United States	13	398 0.8×	155 0.4×	235 0.8×	177 1.0×	83 0.7×	17	721
Xinnuo Xiong China	15	98 0.2×	266 0.7×	120 0.4×	63 0.4×	123 1.0×	25	569
Jack Hu United States	7	265 0.5×	87 0.2×	149 0.5×	90 0.5×	112 0.9×	7	476
Ryuichi Narazaki Japan	12	175 0.4×	253 0.7×	120 0.4×	114 0.7×	62 0.5×	16	597

Countries citing papers authored by Wei‐Qin Tong

Since Specialization

Citations

This map shows the geographic impact of Wei‐Qin Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Qin Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Qin Tong more than expected).

Fields of papers citing papers by Wei‐Qin Tong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Qin Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Qin Tong. The network helps show where Wei‐Qin Tong may publish in the future.

Co-authorship network of co-authors of Wei‐Qin Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Qin Tong. A scholar is included among the top collaborators of Wei‐Qin Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Qin Tong. Wei‐Qin Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Tong, Wei‐Qin & Hong Wen. (2018). Application of Complexation in Drug Development for Insoluble Compounds. 149–175. 1 indexed citations

Tong, Wei‐Qin & Hong Wen. (2018). Preformulation Aspects of Insoluble Compounds. 65–95. 4 indexed citations

Ghosh, Indrajit, et al.. (2011). Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder. International Journal of Pharmaceutics. 419(1-2). 12–19. 69 indexed citations

Vasanthavada, Madhav, Yanfeng Wang, Thomas Haefele, et al.. (2010). Application of Melt Granulation Technology Using Twin-screw Extruder in Development of High-dose Modified-Release Tablet Formulation. Journal of Pharmaceutical Sciences. 100(5). 1923–1934. 49 indexed citations

Lakshman, Jay, et al.. (2010). Application of Melt Granulation Technology to Enhance Tabletting Properties of Poorly Compactible High-Dose Drugs. Journal of Pharmaceutical Sciences. 100(4). 1553–1565. 84 indexed citations

Vasanthavada, Madhav, Simerdeep Singh Gupta, Wei‐Qin Tong, & Abu T.M. Serajuddin. (2008). Development of Solid Dispersion for Poorly Water-Soluble Drugs. 513–544. 9 indexed citations

Vasanthavada, Madhav, Wei‐Qin Tong, Yatindra M. Joshi, & M. Serpil Kislalioglu. (2005). Phase Behavior of Amorphous Molecular Dispersions II: Role of Hydrogen Bonding in Solid Solubility and Phase Separation Kinetics. Pharmaceutical Research. 22(3). 440–448. 140 indexed citations

Vasanthavada, Madhav, Wei‐Qin Tong, Yatindra M. Joshi, & M. Serpil Kislalioglu. (2004). Phase Behavior of Amorphous Molecular Dispersions I: Determination of the Degree and Mechanism of Solid Solubility. Pharmaceutical Research. 21(9). 1598–1606. 109 indexed citations

Tong, Wei‐Qin, et al.. (1998). In Situ Salt Screening-A Useful Technique for Discovery Support and Preformulation Studies. Pharmaceutical Development and Technology. 3(2). 215–223. 81 indexed citations

10.

Cobb, Jeff E., Steven G. Blanchard, Kathleen K. Brown, et al.. (1998). N-(2-Benzoylphenyl)-l-tyrosine PPARγ Agonists. 3. Structure−Activity Relationship and Optimization of the N-Aryl Substituent. Journal of Medicinal Chemistry. 41(25). 5055–5069. 96 indexed citations

11.

Collins, Jon L., Steven G. Blanchard, Paul S. Charifson, et al.. (1998). N-(2-Benzoylphenyl)-l-tyrosine PPARγ Agonists. 2. Structure−Activity Relationship and Optimization of the Phenyl Alkyl Ether Moiety. Journal of Medicinal Chemistry. 41(25). 5037–5054. 68 indexed citations

12.

Tong, Wei‐Qin, et al.. (1996). A Four-Component Study for Estimating Solubilities of a Poorly Soluble Compound in Multisolvent Systems Using a Scheffé-Type Model. Drug Development and Industrial Pharmacy. 22(9-10). 881–889. 4 indexed citations

13.

Luzzio, Michael J., Jeffrey M. Besterman, David L. Emerson, et al.. (1995). Synthesis and Antitumor Activity of Novel Water Soluble Derivatives of Camptothecin as Specific Inhibitors of Topoisomerase I. Journal of Medicinal Chemistry. 38(3). 395–401. 122 indexed citations

14.

Tong, Wei‐Qin, John L. Lach, Ting‐Fong Chin, & J. Keith Guillory. (1991). Structural Effects on the Binding of Amine Drugs with the Diphenylmethyl Functionality to Cyclodextrins. II. A Molecular Modeling Study. Pharmaceutical Research. 8(10). 1307–1312. 18 indexed citations

15.

Tong, Wei‐Qin, John L. Lach, Ting‐Fong Chin, & J. Keith Guillory. (1991). Structural effects on the binding of amine drugs with the diphenylmethyl functionality to cyclodextrins. I. A microcalorimetric study.. Pharmaceutical Research. 8(7). 951–957. 37 indexed citations

16.

Tong, Wei‐Qin, John L. Lach, Ting‐Fong Chin, & J. Keith Guillory. (1991). Microcalorimetric investigation of the complexation between 2-hydroxypropyl-β-cyclodextrin and amine drugs with the diphenylmethyl functionality. Journal of Pharmaceutical and Biomedical Analysis. 9(10-12). 1139–1146. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact